Roth Capital Reiterates Buy on Electromed, Raises Price Target to $36
Benzinga Newsdesk 12 months ago
NewsPrice TargetReiterationAnalyst Ratings
Roth Capital analyst Kyle Bauser reiterates Electromed (AMEX:ELMD) with a Buy and raises the price target from $35 to $36.
Roth Capital analyst Kyle Bauser reiterates Electromed (AMEX:ELMD) with a Buy and raises the price target from $35 to $36.